OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
1025
Results
Show all
Save search
Copy query
Show results for
Unknown
(1019)
Metabolomics
(5)
Genomics
(1)
Organisms
Homo sapiens
(1)
Repository
MetaboLights
(5)
EGA
(1)
Technology Type
Mass spectrometry
(2)
Mass spectrometry assay
(2)
NMR spectroscopy
(1)
Instrument Platform
Liquid Chromatography MS - negative
(2)
Liquid Chromatography MS - positive
(2)
Liquid Chromatography MS - negative - reverse phase
(2)
Liquid Chromatography MS - positive - reverse phase
(2)
Nuclear Magnetic Resonance (NMR) -
(1)
Publication Date
2022
(2)
2026
(1)
2025
(1)
2023
(1)
CHEBI ID
CHEBI:190234
(1)
CHEBI:176755
(1)
CHEBI:89679
(1)
CHEBI:140367
(1)
CHEBI:134649
(1)
CHEBI:136158
(1)
CHEBI:190221
(1)
CHEBI:183176
(1)
CHEBI:136095
(1)
CHEBI:140368
(1)
CHEBI:186031
(1)
CHEBI:72073
(1)
CHEBI:88513
(1)
CHEBI:190162
(1)
CHEBI:190212
(1)
CHEBI:190209
(1)
CHEBI:190208
(1)
CHEBI:190205
(1)
CHEBI:72069
(1)
CHEBI:190201
(1)
CHEBI:190199
(1)
CHEBI:140366
(1)
CHEBI:190197
(1)
CHEBI:134503
(1)
CHEBI:134642
(1)
CHEBI:190195
(1)
CHEBI:190193
(1)
CHEBI:190191
(1)
CHEBI:138555
(1)
CHEBI:187564
(1)
Metabolite Name
LPS(18:2)
(2)
LPS(22:6)
(2)
3-Hydroxybutyrate
(2)
Uracil
(2)
Glycine
(2)
Taurine
(2)
Hypoxanthine
(2)
Sarcosine
(2)
Glutamine
(2)
Glucose
(2)
Asparagine
(2)
Inosine
(2)
Uridine
(2)
PC(41:2p)
(1)
SM(d45:1)(rep)
(1)
SM(d46:4)
(1)
PE(18:0p/22:1)
(1)
SM(d43:1)
(1)
CerG1(d42:1)
(1)
Cer(d42:4)
(1)
SM(d42:0)(rep)
(1)
SM(d44:2)(rep)
(1)
SM(d43:3)(rep)(rep)
(1)
CerG2(d18:1/24:0)
(1)
PE(18:1/21:0)
(1)
PE(18:0p/20:1)
(1)
PE(18:0p/20:1)(rep)
(1)
SM(d41:1)(rep)
(1)
SM(d45:5)
(1)
SM(d40:0)(rep)
(1)
Release Date
2025
(241)
2024
(176)
2023
(145)
2022
(131)
2021
(85)
2020
(71)
2019
(42)
2026
(30)
2018
(27)
2017
(17)
2015
(14)
2016
(13)
2014
(13)
2013
(8)
2012
(2)
2011
(2)
2010
(1)
2009
(1)
Previous
page
1 / 103
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
103
Next
page
Sort
by:
Relevance
Page size
10
Mutation analysis of common deafness genes among 1,201 patients with non-syndromic hearing loss in Shanxi Province.
Not available
S-EPMC6418354
|
biostudies-literature
Cite
Molecular Epidemiology and Antibiotic Resistance Associated with <i>Avian Pathogenic Escherichia coli</i> in Shanxi Province, China, from 2021 to 2023.
Not available
S-EPMC11946381
|
biostudies-literature
Cite
Molecular Diagnosis of Hemophilia A and Pathogenesis of Novel F8 Variants in Shanxi, China.
Not available
S-EPMC10499503
|
biostudies-literature
Cite
Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006-2016.
Not available
S-EPMC6542020
|
biostudies-literature
Cite
Characteristics of the spike and ORF3 genes of porcine epidemic diarrhea virus in Henan and Shanxi provinces of China.
Not available
S-EPMC7382918
|
biostudies-literature
Cite
Knowledge, attitudes and practices regarding pulmonary rehabilitation among patients with chronic respiratory diseases: a cross-sectional questionnaire-based study in a tertiary hospital in China.
Not available
S-EPMC11784421
|
biostudies-literature
Cite
A novel highly fluorescent S, N, O co-doped carbon dots for biosensing and bioimaging of copper ions in live cells.
Not available
S-EPMC9092139
|
biostudies-literature
Cite
Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial.
Not available
S-EPMC8692079
|
biostudies-literature
Cite
Manipulation of the rhizosphere microbial community through application of a new bio-organic fertilizer improves watermelon quality and health.
Not available
S-EPMC5815603
|
biostudies-literature
Cite
Genome-Wide Identification and Expression Profiling of Glutathione
S
-Transferase Gene Family in Foxtail Millet (
Setaria italica
L.).
Not available
S-EPMC10005783
|
biostudies-literature
Cite
Previous
page
1 / 103
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
103
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets